Lawsuit Overview
September 25, 2020 - An investor in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by BioMarin Pharmaceutical Inc. in connection with certain allegedly false and misleading statements made between February 28, 2020 and August 18, 2020. San Rafae...
You must register (for free) or login to view the entire case.